Allele: A Division of Catalyst BC

Allele’s core mission is to combine market–proven cannabis genetics with modern agricultural science with the goal of developing commercial cannabis cultivars to maximize product quality and drive financial performance. Allele sources the highest quality genetic material then, integrates genomic mapping and predictive breeding platforms, and utilizes modern tissue culture procedures to provide turnkey genetics solutions that maximize profit and minimize risk for large-scale commercial cannabinoid production.

Genetics Improvement:

Allele will work alongside your cultivation team to identify specific genetic development needs in order to design and implement propagation and breeding programs that will produce unique and proprietary cultivars, providing maximized productivity and profitability. We have developed a dynamic and growing portfolio of unique, exotic and desirable cannabis genetics that exhibit elevated levels of resin content, terpenes, and cannabinoids (THC-A, CBD, CBG, and CBC). Our cultivars have years of proven commercial viability in multiple markets utilizing many types of cultivation methods.  We will work with you to determine your company’s specific genetic needs and implement breeding programs that produce unique and proprietary cultivars that allow you to maximize productivity and profit.  By using the latest genomic mapping, laboratory grade tissue culture and micropropagation techniques we are providing science backed cannabis genetics to a modern market.

Service offerings include:

Award Winning & Proven Cannabis Genetics
Unreleased, Non-Market Exposed Cannabis Genetics
Cannabis Genetics Development
Cannabis Genetics Preservation
Micropropagation (International only)
Targeted Pollination
Seed Production
Genetics Consulting
Genetics Selection
Production Planning

Additional Resources

Consulting Services For Cannabis, Hemp, Psilocybin, and Natural Medicine

Testimonials and Public Relations

Latest Articles

Cannabis HVAC Design: The Psychrometrics of Profit and Operational Scalability in 2026
In 2026, the global cannabis market has moved into a “Pharma-Grade” era. As of 2026, the leading cultivators are no longer just managing “temperature and humidity.” They are managing Vapor Pressure Deficit (VPD) and Biogenic Volatile Organic Compounds (BVOCs) to maximize secondary metabolite production (terpenes and cannabinoids) while slashing carbon footprints.
The 2026 Strategic Play: Mastering the New York Adult-Use Processor Type 3 Branding License
In 2021, New York legalized. In 2025, it launched. In April 2026, the market is maturing at an unprecedented rate. The “green rush” of speculative applications has been replaced by a sophisticated “Branding Phase.” As of this month, the Office of Cannabis Management (OCM) has authorized over 532 processors, many of whom are actively seeking high-quality brand partners to fill their white-label capacity.
Don’t Get Left Behind: Securing Your New York Cannabis License in 2026
The era of “provisional waiting” is over. The Office of Cannabis Management (OCM) has now issued over 2,160 adult-use licenses statewide. For entrepreneurs, the message is clear: the market is live, the supply chain is scaling, and the opportunity for professional, compliant operators has never been greater.
Overcoming the Complexities of Minnesota Cannabis Licensing in 2026: Navigating the Scale-Up Phase
In 2026, Minnesota’s cannabis market has transitioned from initial launch to a high-stakes scale-up phase. To succeed, applicants must move beyond basic requirements to demonstrate “pharma-grade” compliance, long-term financial stability, and total operational readiness. We have outlined the most critical hurdles currently facing 2026 applicants – from navigating the 65% social equity ownership audit to overcoming the statewide testing bottleneck.
Cannabis Consumption Lounges: Which States Permit On-Site Use in 2026?
Across much of the U.S., legally consuming cannabis remains largely restricted to private residences – and even then, landlords or HOAs frequently ban it. While retail sales are now legal in the majority of the country, a growing number of jurisdictions are finally moving beyond the “buy-it-and-go” model, authorizing public venues where adults can consume their purchases on-site in a social, regulated setting.
Virginia Cannabis Licensing & Business Opportunities (Updated April 2026)
As Virginia transitions from its current “possession-only” model toward a fully regulated retail market, the 2026–2027 biennium represents a once-in-a-generation window for market entry. Unlike the vertically integrated “medical-only” regimes of the past, Virginia’s upcoming framework focuses on decentralization, specifically architected to favor small Virginia-based operators over large multi-state corporations.